Trial · NCT06912828
GWAS to Identify Predictive Genetic Factors for the Success of Dietary Intervention in the Treatment of IBS Symptoms
This is a GWAS that aims to identify possible single nucleotide polymorphisms (SNPs) that are associated with the response in a combined dietary pattern low in
- Status
- Recruiting
- Sponsor
- Attikon Hospital
- Study type
- Observational
- Phase
- Not applicable
- Enrollment
- 100 participants (planned)
- Start
- Sep 15, 2024
- Primary completion
- Sep 15, 2026
- Conditions
- Irritable Bowel Syndrome (IBS), Genome-wide Association Study, Single Nucleotide Polymorphisms, Mediterranean Diet, FODMAP Diet
Summary
This is a GWAS that aims to identify possible single nucleotide polymorphisms (SNPs) that are associated with the response in a combined dietary pattern low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols and Meditteranean diet (MED-LFD) in a small group of patients with Irritable Bowel Syndrome (IBS).
Interventions
- Med-LFD intervention Other
Locations
1 country: Greece.
| Facility | City | Country |
|---|---|---|
| Attikon General University Hospital of Athens | Athens | Greece |
TreatIBS is an informational site and does not provide medical advice. The research summarized here may not apply to your situation. Talk with a clinician before starting, stopping, or changing any treatment.
Listing only. Eligibility is decided by the study team. TreatIBS is not involved in recruitment.